Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

12.07.2018 | Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development ...

Scientist (f/m) – Analytics in Early Process Development

10.07.2018 | Design. Progress. Together. CureVac AG is a biopharmaceutical company researching, developing and producing novel drugs based on the natural molecule Messenger RNA (mRNA). ...

Ideas brought to life in Anatomy

10.07.2018 | Incisions and insights workshop series – “Heart, lungs, thorax” The “Incisions and insights – medtech engineers and medical practitioners in dialogue” workshop series continued in June ...

Site-directed RNA editing as an alternative to genetic scissors

05.07.2018 | Tübingen researchers use cells’ backup copies for targeted, reversible changes to genetic information – seeking applications in research and treatment of ...